“At 8 am, the infusion chairs are already full. The oncologist is in a room seeing a new patient consult, the pharmacist is adjusting doses based on new lab values, and the advanced practitioner (AP) is sitting with a patient—reviewing symptoms, discussing how to manage treatment side effects, and helping determine whether treatment should proceed that day. This scene plays out daily in oncology practices across the country and reflects a reality many physicians know well: modern cancer care is a team effort, and APs are central to this scenario.”
Researchers clinically validated a sensitive blood test as a whole-genome sequencing assay for detecting circulating tumor human papillomavirus (HPV) DNA in patients with HPV-associated head and neck cancer after surgery to search for residual disease as a sign of potential recurrence.
He brings more than 25 years of urologic surgery experience to the role, including 15 years specializing in robotic urologic oncology procedures. As only the second urologist and third Black physician overall to serve as AMA President, he is committed to advancing patient-centered care and addressing longstanding health disparities through improved access, prevention, and coordinated care.
|
